Iriflophenone
CAS No. 52591-10-3
Iriflophenone ( —— )
产品货号. M29166 CAS No. 52591-10-3
Iriflophenone?stimulates cells proliferation in??MCF-7 and T-47D human breast cancer.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥3013 | 有现货 |
|
10MG | ¥4504 | 有现货 |
|
25MG | ¥7258 | 有现货 |
|
50MG | ¥9882 | 有现货 |
|
100MG | ¥13365 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Iriflophenone
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Iriflophenone?stimulates cells proliferation in??MCF-7 and T-47D human breast cancer.
-
产品描述Iriflophenone?stimulates cells proliferation in??MCF-7 and T-47D human breast cancer.(In Vitro):2,2'-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity was used to evaluate the antioxidant capacity of the CPE. Experimental results concluded that ethanol concentration and solid-to-solvent ratio had significant effects (p<0.05) on the yields of polyphenol and antioxidant capacity. Extraction time had an insignificant influence on the recovery of EGCG, ECG and Iriflophenone 3-C-β-glucoside, as well as radical scavenging capacity from the CPE. The extraction parameters that exhibited maximum yields were 40% (v/v) ethanol, 1:60 (w/v) for 30 min where the TPC, TFC, TF, DPPH, EGCG, ECG and Iriflophenone 3-C-β-glucoside levels achieved were 183.5 mg GAE/g DW, 249.0 mg QE/g DW, 4.9 mg CE/g DW, 93.7%, 29.1 mg EGCG/g DW, 44.3 mg ECG/g DW and 39.9 mg Iriflophenone 3-C-β-glucoside/g DW respectively. The IC50 of the CPE was 24.6 mg/L.
-
同义词——
-
通路Endocrinology/Hormones
-
靶点Estrogen Receptor/ERR
-
受体Estrogen Receptor/ERR
-
研究领域——
-
适应症——
化学信息
-
CAS Number52591-10-3
-
分子量246.2
-
分子式C13H10O5
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOc1ccc(cc1)C(=O)c1c(O)cc(O)cc1O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
XCT790
A potent and selective ERRα inverse agonist with IC50 of 300-500 nM in transient transfection assays.
-
Liquiritigenin
Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes
-
LSZ102
LSZ102 is a potent, orally bioavailable, selective estrogen receptor degrader (SERD) with ERα transcription IC50 of 6 nM and ERα degradation IC50 of 0.2 nM.